RxDoctor Payments Data

Ann Vandewalle Jones, MD

Neurology · Indianapolis, INNPI 1457715559

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $571 of the $861 with a category attached, or 66.3%. Every reported general payment came from a single manufacturer, Janssen Research & Development, LLC. That places this record below the midpoint for neurology clinicians in IN, where the typical reported total is $1,614.

$861in general payments, 2019–2025

Across 8 payments — averaging $107.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$861
$174,059in research payments, 2019–2025

Across 41 payments — averaging $4245.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$174K

What the payments were for

  • Travel & lodging$57166%
  • Food & beverage$29034%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC8$861

How this compares

$861 in reported general payments places this provider in the 40th percentile of 308 neurology providers in Indiana.

See all neurology providers in Indiana

Medicare billing

Part B allowed, 2024
$37,710
Medicare patients
176
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lacosamide18$5,436
Levetiracetam36$577
Gabapentin34$461
Carbidopa-LevodopaCarbidopa/Levodopa19$433
Memantine Hcl16$233
Rosuvastatin Calcium15$145
Atorvastatin Calcium25$136
Lamotrigine17$82

Paid to pharmacies, not to this prescriber.

Other neurology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →